Abstract
OMIM: #276700 (TYPE 1)/276600 (TYPE2)/276710 (TYPE3)
Similar content being viewed by others
References
Bliksrud YT, Brodtkorb E, Andresen PA, van den Berg IET, Kvittingen EA (2005) Tyrosinaemia type I–de novo mutation in liver tissue suppressing an inborn splicing defect. J Mol Med 83:406–410. https://doi.org/10.1007/s00109-005-0648-2
Chinsky JM et al (2017) Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet Med:19. https://doi.org/10.1038/gim.2017.101
Heylen E, Fau SG, Fau VM, Fau MS, Fau FJ, Nassogne MC (2012) Tyrosinemia type III detected via neonatal screening: management and outcome. Mol Genet Metab 107(3):605–607
Kvittingen EA, Halvorsen S, Jellum E (1983) Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia. Pediatr Res 17:541–544. https://doi.org/10.1203/00006450-198307000-00005
Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340:813–817. https://doi.org/10.1016/0140-6736(92)92685-9
Macsai MS, Fau ST, Fau HD, Fau HM, Fau MM, Rootman D (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophthalmol 132(4):522–527
Natt E, Westphal E-M, Toth-Fejel SE, Magenis RE, Buist NRM, Rettenmeier R, Scherer G (1987) Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1 → q22.3 in a patient with tyrosinemia type II. Hum Genet 77:352–358. https://doi.org/10.1007/BF00291426
Rüetschi U, Cerone R, Pérez-Cerda C, Schiaffino MC, Standing S, Ugarte M, Holme E (2000) Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III. Hum Genet 106:654–662. https://doi.org/10.1007/s004390000307
Tomoeda K et al (2000) Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab 71:506–510. https://doi.org/10.1006/mgme.2000.3085
Westphal E-M, Natt E, Grimm T, Odievre M, Scherer G (1988) The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II. Hum Genet 79:260–264. https://doi.org/10.1007/BF00366248
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Barzegary, A., Noroozi, A., Karimi, A., Rezaei, N. (2023). Tyrosinemia (TYRSN). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1802-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-66816-1_1802-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66816-1
Online ISBN: 978-3-319-66816-1
eBook Packages: Springer Reference MedicineReference Module Medicine